Use of transgenic Aedes aegypti in Brazil: risk perception and assessment

The OX513A strain of Aedes aegypti, which was developed by the British company Oxitec, expresses a self-limiting transgene that prevents larvae from developing to adulthood. In April 2014, the Brazilian National Technical Commission on Biosafety completed a risk assessment of OX513A and concluded th...

Descripción completa

Detalles Bibliográficos
Autores principales: Paes de Andrade, Paulo, Aragão, Francisco José Lima, Colli, Walter, Dellagostin, Odir Antônio, Finardi-Filho, Flávio, Hirata, Mario Hiroyuki, Lira-Neto, Amaro de Castro, Almeida de Melo, Marcia, Nepomuceno, Alexandre Lima, Gorgônio da Nóbrega, Francisco, Delfino de Sousa, Gutemberg, Valicente, Fernando Hercos, Zanettini, Maria Helena Bodanese
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2016
Materias:
Policy & Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043214/
https://www.ncbi.nlm.nih.gov/pubmed/27843167
http://dx.doi.org/10.2471/BLT.16.173377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043214/
https://www.ncbi.nlm.nih.gov/pubmed/27843167
http://dx.doi.org/10.2471/BLT.16.173377

Ejemplares similares